Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers
- PMID: 85676
- DOI: 10.1016/0022-1759(79)90025-5
Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers
Abstract
A coupling method for covalent attachment of acid labile oligosaccharides isolated from S. typhimurium O-polysaccharide to macromolecular carriers is described. Arylamine groups were introduced into the terminal reducing end of oligosaccharides by reacting them with 2-(4-aminophenyl)-ethylamine. After subsequent conversion to the corresponding saccharide-phenylisothiocyanato derivatives saccharides were covalently linked to free epsilon-lysylamine groups of different carrier proteins. The resulting conjugates were highly immunogenic and elicited in rabbits both anti-harptenic and anti-carrier protein specific antibodies. Some of the advantages of this coupling procedure are: (i) it can be used with oligosaccharides containing highly acid or alkali labile structures and/or glycosidic linkages, (ii) it produces conjugates with high degrees of substitution at low saccharide/protein molar input ratios, (iii) it does not grossly affect the immunogenic specificities of the carrier protein, and (iv) it is suitable for preparation of highly substituted affinity columns, e.g., coupling to a polyacrylamide matrix.
Similar articles
-
Immunochemistry of Salmonella O-antigens: specificity of rabbit antibodies against the O-antigen 4 determinant elicited by whole bacteria and O-antigen 4 specific saccharide-protein conjugates.J Immunol. 1979 Sep;123(3):1376-81. J Immunol. 1979. PMID: 89168 No abstract available.
-
Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolysaccharide of Neisseria gonorrhoeae P9.J Immunol Methods. 1982;48(2):233-40. doi: 10.1016/0022-1759(82)90197-1. J Immunol Methods. 1982. PMID: 6120197
-
Protection against mouse typhoid by artificial Salmonella vaccines.Scand J Infect Dis Suppl. 1980;Suppl 24:210-5. Scand J Infect Dis Suppl. 1980. PMID: 6163199
-
Immunochemistry of some bacterial oligosaccharide protein conjugates.Ann Sclavo Collana Monogr. 1986;3(1-2):359-66. Ann Sclavo Collana Monogr. 1986. PMID: 3501300 No abstract available.
-
Methods in enzymology: O-glycosylation of proteins.Methods Enzymol. 2005;405:139-71. doi: 10.1016/S0076-6879(05)05007-X. Methods Enzymol. 2005. PMID: 16413314 Review.
Cited by
-
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.Infect Immun. 1992 Oct;60(10):4009-14. doi: 10.1128/iai.60.10.4009-4014.1992. Infect Immun. 1992. PMID: 1398913 Free PMC article.
-
Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis.Infect Immun. 1981 May;32(2):497-502. doi: 10.1128/iai.32.2.497-502.1981. Infect Immun. 1981. PMID: 7019072 Free PMC article.
-
Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.Infect Immun. 1985 Feb;47(2):421-8. doi: 10.1128/iai.47.2.421-428.1985. Infect Immun. 1985. PMID: 3881349 Free PMC article.
-
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Microbiol Rev. 1993 Mar;57(1):34-49. doi: 10.1128/mr.57.1.34-49.1993. Microbiol Rev. 1993. PMID: 8464406 Free PMC article. Review.
-
Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.Infect Immun. 2016 Jun 23;84(7):2059-2075. doi: 10.1128/IAI.00139-16. Print 2016 Jul. Infect Immun. 2016. PMID: 27113360 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources